Allianz Asset Management’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-22,854
Closed -$1.01M 2192
2024
Q1
$1.01M Buy
+22,854
New +$1.01M ﹤0.01% 1411
2017
Q1
Sell
-45,211
Closed -$502K 2621
2016
Q4
$502K Sell
45,211
-11,177
-20% -$120K ﹤0.01% 2370
2016
Q3
$958K Sell
56,388
-9,752
-15% -$181K ﹤0.01% 2221
2016
Q2
$1.44M Sell
66,140
-1,962
-3% -$35.3K ﹤0.01% 2055
2016
Q1
$1.3M Sell
68,102
-301
-0.4% -$5.76K ﹤0.01% 1982
2015
Q4
$1.92M Sell
68,403
-3,502
-5% -$99K ﹤0.01% 1723
2015
Q3
$1.75M Buy
+71,905
New +$1.72M ﹤0.01% 1636

Other funds holding IRMD

Allianz Asset Management's IRMD Position: Q2 2024 in Review

Allianz Asset Management sold out of iRadimed (IRMD) in Q2 2024, closing a stake of 22,854 shares — an estimated $1.01M sold.

Allianz Asset Management first reported a position in IRMD in Q3 2015 and held it in 7 quarters. The position peaked at $1.92M in Q4 2015. 139 funds tracked by Wall St. Rank hold IRMD as of Q2 2024.

  • Allianz Asset Management reported no remaining iRadimed position as of Q2 2024 after selling out during the quarter.
  • Allianz Asset Management sold 22,854 iRadimed shares in Q2 2024, an estimated $1.01M.
  • Allianz Asset Management first reported a position in iRadimed in Q3 2015 and held it in 7 quarters.
  • Allianz Asset Management's iRadimed position peaked at $1.92M in Q4 2015.
  • 139 funds tracked by Wall St. Rank held iRadimed as of Q2 2024.

Based on Allianz Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.